Products

Fierce Biotech

Established Leader

Fierce Biotech News & Reports

fiercebiotech.com Industry Software / Life Sciences & Biotech

AI Benchmark
Desktop
Mobile
Monthly visits
884.3K
Up18.2%MoMSep 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
FierceBiotech
@fiercebiotech· 102.8K followers
Launched
10y ago
2016-03-25 · Est.

Traffic

Monthly visitsData through Sep 2026
Events11 changes · 5 marketing moves

Marketing moves

Launches, search & content, referrals, promotions
  • Fierce Biotech covers Rezera's $181 million IPO targetReferrals & Backlinks

    Fierce Biotech reports that Rezera, formerly NodThera, is targeting $181 million in IPO proceeds to fund a phase 3 trial for its lead NLRP3 inhibitor.

    Nov 5 · 9d agoX Post

  • Fierce Biotech covers Evommune's $1.1B deal with Hinova PharmaReferrals & Backlinks

    Fierce Biotech reports that Evommune signed a deal worth up to $1.1 billion with Hinova Pharmaceuticals to develop VAV1-targeting molecular glue degraders.

    Nov 5 · 9d agoX Post

  • Fierce Biotech covers Sanofi ending STAT6 degrader trial with NurixReferrals & Backlinks

    Fierce Biotech reports that Sanofi is pulling the plug on a STAT6 degrader licensed from Nurix just two months after launching a phase 1 trial. The decision comes amid a broader pipeline shake-up under Sanofi's new CEO.

    Nov 4 · 10d agoX Post

  • Fierce Biotech covers Boehringer Ingelheim's $7.4B deal with Sino BiopharmaceuticalReferrals & Backlinks

    Fierce Biotech reports that Boehringer Ingelheim entered into a deal worth up to $7.4 billion with Sino Biopharmaceutical for six preclinical cancer programs spanning ADCs and T-cell engagers.

    Nov 4 · 10d agoX Post

  • Fierce Biotech covers Novo Nordisk seeking acquisitions to fill pipeline gapsReferrals & Backlinks

    Fierce Biotech reported that Novo Nordisk is continuing to pursue acquisitions to fill pipeline gaps following $2.2 billion in impairment charges that affected quarterly profits.

    Nov 4 · 10d agoX Post

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Direct39%
  • Organic Search35%
  • Referrals11%
  • Email8%
  • Other6%

Countries

  • United States71%
  • China6%
  • United Kingdom4%
  • South Korea2%
  • Canada1%

Search

Domain authority —Domain registered 2000-03-26

KeywordMonthly volume
novartis102.5K
fierce biotech7,820
biotech buyouts sept 20262,220
fiercebiotech510
novo walks away from $285m pact to develop monthly glp-1 obesity drug with ascendis—

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2016-03-25

Key pages

Weekly snapshots

Changes

  1. Nov 1 · 13d ago

    Homepage headline (H1) changed to “How Boston biotechs cope with shallower pool of seed funding”Positioning

    NOW PLAYING→How Boston biotechs cope with shallower pool of seed funding

  2. Nov 1 · 13d ago

    Adopted technology: AdRollFeatures

    —→AdRoll

  3. Nov 1 · 13d ago

    Adopted technology: AdRoll CMP SystemFeatures

    —→AdRoll CMP System

  4. Nov 1 · 13d ago

    Adopted technology: Cloudflare Bot ManagementFeatures

    —→Cloudflare Bot Management

  5. Nov 1 · 13d ago

    Adopted technology: Drupal MultisiteFeatures

    —→Drupal Multisite

  6. Nov 1 · 13d ago

    Adopted technology: Facebook PixelFeatures

    —→Facebook Pixel

Design

First-screen visual analysis & :root CSS

Enterprise Clean (Dark canvas, dense density) featuring split copy & visual layout and photography / live video visuals.

First-screen preview · click to zoom

First-screen pitch & conversion flow

“Why experts fear fallout from Treasury’s China biotech crackdown”

Split Copy & Visual hero structure paired with start free / sign up CTA and no explicit trust bar.

Conversion path: Split Copy & Visual + Photography / Live Video → Start Free / Sign Up

  • Brand Manifesto & Curiosity

Palette · click to copy

5-D design score7.1 / 10
Typography
7.0
Color & Contrast
7.0
Layout & Spacing
8.0
Craft & Polish
7.0
Distinctiveness
6.0

Structure

Fonts
Overpass
Primary visual
Photography / Live Video
Conversion CTA
Start Free / Sign Up
Social proof
No Explicit Trust Bar
Navigation
Full-Width Top Bar
Theme & density
Dark · Dense
Corners & depth
Small Radius · Hairline borders
Preview full AI design brief (includes :root CSS variables & layout rules)Style tokens only; never copy brand names, logos, copy, or images
# Design Brief: Enterprise Clean (with Editorial)

Trustworthy blue-anchored palette, structured grids, and prominent customer logo walls.

## Design Tokens

```css
:root {
  --background: #073b50;
  --surface: #0b4c63;
  --foreground: #f5f7f8;
  --muted-foreground: #b8cdd5;
  --accent: #ed2028;
  --radius: 4px;
  --font-heading: "Overpass", ui-sans-serif, system-ui, sans-serif;
  --font-body: "Overpass", ui-sans-serif, system-ui, sans-serif;
}
```

Color area ratio: Background #073B50 (~66%) · Surface #0B4C63 (~18%) · Text #F5F7F8 (~9%) · Muted Text #B8CDD5 (~4%) · Accent #ED2028 (~3%). Background and surface dominate the canvas; reserve the accent color for primary buttons and active states.

## Layout & Conversion Structure

- Hero layout: Split Copy & Visual
- Navigation: Full-Width Top Bar
- Theme & density: Dark · Dense
- Border radius & elevation: Small Radius; no drop shadows—separate layers with hairline borders and whitespace
- Primary visual medium: Photography / Live Video
- Conversion CTA: Start Free / Sign Up
- Headline hook: Brand Manifesto & Curiosity
- Spatial layout notes: Split Copy & Visual hero structure paired with start free / sign up CTA and no explicit trust bar.
- Visual summary: Enterprise Clean (Dark canvas, dense density) featuring split copy & visual layout and photography / live video visuals.

## Avoid

- Experimental navigation patterns
- Low-legibility decorative fonts
- Visual novelty that obscures the value proposition

Implement the UI following the design tokens and layout specifications above: use only these color variables, and reserve the accent color strictly for primary actions and active states. Adopt only this visual style—never copy any reference product’s brand name, logo, copy, or imagery.

Questions & evidence

How much website traffic does Fierce Biotech get?
Vaneform estimates 884.3K website visits in 2026-09. Visits can include repeat visits; this estimate does not measure paying customers or revenue.Source

Related products in this category

Industry Software / Life Sciences & Biotech

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.